Amanote Research
Register
Sign In
Towards De-Escalation of Axillary Management After Neoadjuvant Chemotherapy in Breast Cancer
doi 10.26481/dis.20191218js
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
University of Maastricht
Related search
Axillary and Internal Mammary Sentinel Lymph Node Biopsy in Breast Cancer After Neoadjuvant Chemotherapy
Oncotarget
Oncology
Neoadjuvant Chemotherapy in Breast Cancer
Axillary Ultrasound Before Neoadjuvant Chemotherapy for Breast Cancer: Don’t Discount the Benefits Yet!
Annals of Surgical Oncology
Oncology
Surgery
Role of Percutaneous Needle Biopsy of Axillary Lymph Nodes to Evaluate Node Positive Breast Cancer After Neoadjuvant Chemotherapy
Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences
Multidisciplinary
Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer
Breast Care
Surgery
Oncology
Ki67 Measured After Neoadjuvant Chemotherapy for Primary Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Neoadjuvant Chemotherapy: Role in Breast Cancer
A New Model Incorporating Axillary Ultrasound After Neoadjuvant Chemotherapy to Predict Non-Sentinel Lymph Node Metastasis in Invasive Breast Cancer
Cancer Management and Research
Oncology
Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer
Journal of Medical – Clinical Research & Reviews
